Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06864338 · ClinicalTrials.gov registry record
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
A clinical trial of Colorectal Cancer Screening and Colorectal Cancer Metastatic, sponsored by Mainz Biomed.
- Recruiting
- Registry status
- 2,700
- Enrollment target
- 1
- Study location
NCT06864338: Recruiting study of Colorectal Cancer Screening and Colorectal Cancer Metastatic, sponsored by Mainz Biomed.
NCT06864338 is a study of Colorectal Cancer Screening and Colorectal Cancer Metastatic that is actively recruiting participants, run by Mainz Biomed. The registered enrollment target is 2,700 participants, below the 5,741-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06864338, a study of Colorectal Cancer Screening and Colorectal Cancer Metastatic, is actively recruiting participants, sponsored by Mainz Biomed.
- RECRUITING
- Registry status
- 2,700 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.
Primary Outcome
Test results will be used for the feasibility, test optimization, algorithm, and cut- off ranges for the Mainz Biomed Colorectal Cancer Screening Test.
Conditions Studied
Study Locations (1)
North Carolina
- Virtual Research Group - Morrisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2022-12-18 |
| Est. Completion | 2025-11-30 |
What NCT06864338 shows while recruiting
NCT06864338 is an observational study that tracks outcomes without assigning an intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, below the 5,741-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (53% lower).
The record links to 3 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 0 interventions.
NCT06864338 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06864338 about?
NCT06864338 is a clinical study titled "Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test". The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.
What is the current status of trial NCT06864338?
This trial is currently recruiting. The enrollment target is 2,700 participants. The study started on 2022-12-18. Estimated completion is 2025-11-30.
What conditions does trial NCT06864338 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening, Colorectal Cancer Metastatic, Colon Adenocarcinoma.
Who is sponsoring clinical trial NCT06864338?
This trial is sponsored by Mainz Biomed, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06864338 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06864338's enrollment target sits among peer trials
2,700 6th of 19 higher than 14 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
CRC Screening in Unscreened Individuals 45-54
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI